Related Experiment Video
Updated: Feb 26, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
930
Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance
Marc A Dall'Era1, Benjamin J Davies2
1Department of Urology, University of California Davis, Davis Medical Center, Sacramento, CA, USA.
European Urology Focus
|July 21, 2017
Abstract:
Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.

